MétaCan
Menu
Retour à la cohorte
Enregistrement W2089980444 · doi:10.1213/01.ane.0000271915.56275.0c

Phenoxybenzamine Is Indicated in Treatment of Hypoplastic Left Heart Syndrome: Pro

2007· letter· en· W2089980444 sur OpenAlexfundaboutno aff
Eckehard A. E. Stuth

Notice bibliographique

RevueAnesthesia & Analgesia · 2007
Typeletter
Langueen
DomaineMedicine
ThématiqueCardiac Arrest and Resuscitation
Établissements canadiensnon disponible
Organismes subventionnairesHospital for Sick Children
Mots-clésMedicineHypoplastic left heart syndromeNorwood procedureCardiologyAfterloadHeart bypassInternal medicineAnesthesiaCardiopulmonary bypassVascular resistanceVasoconstrictionPerioperativeHypoxic pulmonary vasoconstrictionPulmonary arteryVentricleHemodynamicsHeart disease

Résumé

récupéré en direct d'OpenAlex

Dr Guzetta's review (1) prominently refers to our experience with phenoxybenzamine (POB) at Children's Hospital of Wisconsin (2–5) and she chose to highlight the risk of sudden increases in systemic afterload on systemic oxygen delivery after the Norwood procedure with one of our published recordings (Fig. 4 in Refs. 1 and 6). Although publications on the use of POB are few, the available data provide persuasive evidence in favor of intense and sustained afterload reduction for Norwood palliation. Cardiopulmonary bypass with deep hypothermia, surgical trauma, and arterial hypoxemia contribute to an intense perioperative stress response during Norwood palliation of hypoplastic left heart syndrome, which results in significant morbidity (7). This stress response is characterized by potent activation of the sympathetic nervous system (8) and the renin-angiotensin axis (9,10), and leads to pronounced vasoconstriction of regional vascular beds, in particular the mesenteric circulation (8–10). Such vasoconstriction can result in end-organ ischemia and multiple-organ dysfunction. Use of POB at initiation of pediatric cardiopulmonary bypass results in more effective and homogenous warming and cooling of children during cardiopulmonary bypass and a lower perioperative base deficit, suggesting better organ perfusion and peripheral circulation (11,12). In the postoperative Norwood circulation, the size of the systemic to pulmonary artery interposition shunt is the main determinant of total pulmonary resistance to blood flow and constrains the pulmonary to systemic blood flow (Qp/Qs) ratio (13). A Qp/Qs close to 1:1 results in a balanced parallel circulation which minimizes single ventricle work (13,14). In a full-term neonate (≥3 kg) a 3.5-mm diameter interposition shunt is most likely to result in a balanced circulation after full myocardial and circulatory recovery. This shunt size provides optimal systemic oxygen delivery, even if endogenous pulmonary vascular resistance is moderately increased (13), whereas larger interposition shunts lead to pulmonary over-circulation with the risk of systemic hypoperfusion (13). Smaller, more restrictive shunts avoid pulmonary over-circulation but can result in severe perioperative hypoxemia and need for revision. The single ventricle after Norwood palliation is highly afterload-sensitive. Ventricular output and systemic oxygen delivery decline exponentially with increasing systemic vascular resistance in the Norwood circulation, even in the presence of an optimally sized shunt (13). Therefore, rational postoperative management should be directed at controlling systemic afterload. Although randomized trials that compare afterload-reducing strategies have not been performed, sustained afterload reduction with POB is supported by prospective physiological data showing perioperative stabilization of the parallel circulation, improved oxygen delivery (3,4), and excellent outcomes (5,15). Conversely, in the absence of sustained afterload reduction, sudden unexpected circulatory collapse has been reported with distressing frequency in the early postoperative period after Norwood palliation. Such unexpected circulatory collapse has been associated with sudden fluctuations in systemic vascular resistance (15,16), which can lead to ventricular dysfunction, pulmonary over-circulation with systemic hypoperfusion and myocardial ischemia. A single initial loading dose of POB (0.25 mg/kg) results in low systemic vascular resistance on cardiopulmonary bypass (3,4) and sustained postoperative afterload reduction, which may persist for 72 hours. Our prospective database suggests that such a sustained effect is advantageous, because sudden, unpredictable increases in systemic afterload during the postoperative period are reliably prevented or blunted (15), and systemic oxygen delivery is optimized by “clamping” the Qp/Qs closer to unity (3). Sustained stable afterload reduction facilitates recovery of single ventricle function and stabilizes the parallel circulation during the most vulnerable first 72 hours. In a consecutive series of 105 patients undergoing the Norwood operation at the Hospital for Sick Children in Toronto, 25 patients had acute circulatory collapse in the first 72 hours postoperatively. Thirteen of these patients appeared clinically stable, but had early sudden collapse without apparent cause. Sixteen of the 25 neonates died. In those patients in whom the operation was deemed technically successful, intense afterload reduction with POB reduced the incidence of early sudden circulatory collapse from 31% to 5% (15). Similarly, multivariate analysis in 115 neonates undergoing Norwood palliation at Children's Hospital of Wisconsin, which compared the patient survival from the pre-POB era to the POB era, showed that intense afterload reduction with POB and continuous venous saturation monitoring were the factors significantly associated with improved survival. POB not only decreases systemic vascular resistance, minimizes Qp/Qs imbalance, and improves systemic oxygen delivery (3), but also simplifies postoperative ventilatory and inspiratory gas management. During afterload reduction with POB systemic oxygen delivery remains adequate, even at high arterial oxygen saturations, whereas in the absence of adequate afterload reduction high arterial oxygen saturations are associated with pulmonary over-circulation and systemic hypoperfusion (4). This uncoupling of arterial oxygen saturation from systemic oxygen delivery by POB is advantageous because it allows the use of higher inspired oxygen concentrations postoperatively, which prevents unrecognized pulmonary venous desaturation and its deleterious effect on systemic oxygen delivery (17). A POB-based strategy results in low systemic vascular resistance with the goal of achieving high systemic flows. This strategy is only safe and successful with strict adherence to well-defined hemodynamic and oxygen delivery goals, which requires not only arterial blood pressure monitoring but also continuous monitoring of oxygen delivery with such modalities as continuous venous (superior vena cava) oximetry and two-site near-infrared spectroscopy (3,6,18). POB profoundly changes the way adjunctive vasoactive drugs are used. We routinely use milrinone, but injudicious use of adrenaline can lead to hypotension via β-adrenergically mediated vasodilatation in the presence of α-adrenergic blockade. Therefore, noradrenalin should be used initially as the primary catecholamine. High doses of noradrenalin and adrenaline (up to 0.5 μg · kg−1 · min−1) may be required to separate from bypass, but catecholamine infusions can usually be decreased rapidly to more moderate rates (0.05–0.2 μg · kg−1 · min−1) during modified ultrafiltration. We also routinely use high-dose opiate (7) and high-dose aprotinin regimens, delayed sternal closure, corticosteroids, and modified ultrafiltration. Most importantly, we closely monitor mean arterial blood pressure, systemic oxygen delivery, and regional oxygenation with continuous venous oximetry and two-site near infrared spectroscopy (18). It is crucial to promptly correct inadequate mean arterial blood pressures (<45 mm Hg) and impairments in systemic oxygen delivery (venous saturation <50%) by optimizing preload, hematocrit, and inotropes. Recent data from our institution suggest that POB is also beneficial for managing the Sano modification of Stage 1 palliation (19). Because IV POB is not approved for the described indication, Food and Drug Administration approval and an investigational drug number are required as part of a protocol for research or compassionate use. The decision to incorporate POB into a perioperative Norwood management strategy requires careful planning and full engagement of the entire perioperative team to realize improvements in outcome. ACKNOWLEDGMENTS The authors acknowledges and thanks Professor George Hoffman, MD, Medical Director of Pediatric Anesthesia and Co-director of the Pediatric Intensive Care Unit, Children's Hospital of Wisconsin for his expert advice and review.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,001
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: aucune
GenreSignal candidat: Commentaire · Signal consensuel: aucune
Score de désaccord entre enseignants0,001
Score d'incertitude au seuil0,004

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0000,001
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0010,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0010,001
Charge utile insuffisante (le modèle a refusé de juger)0,0010,001

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,018
Tête enseignante GPT0,274
Écart entre enseignants0,256 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeSans objet
Domainenon disponible
GenreCommentaire

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations5
Publié2007
Routes d'admission2
Résumé présentoui

Explorer davantage

Même revueAnesthesia & AnalgesiaMême sujetCardiac Arrest and ResuscitationTravaux en français237 207